+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Bioprocess Containers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • ID: 4896349
  • Report
  • January 2022
  • Region: Global
  • 112 Pages
  • Mordor Intelligence


  • Avantor Inc
  • Cole-Parmer Instrument Co
  • Danaher Life Sciences
  • General Electric Co
  • Lonza Group AG
  • Merck KGaA

The Bioprocess Containers Market studied was anticipated to grow with a CAGR of nearly 12.2% during the forecast period. The major factors attributing to the growth of the market are the rise in the global prevalence of cancer and immunological disorder cases that necessitate the requirement for vaccines and biologics coupled with the increased preference for Immunotherapy to the Chemotherapy fuels the demand for the bioprocess containers. For instance, according to the American Cancer Society report, In 2019, about 1,762,450 new cancer cases were diagnosed and 606,880 cancer deaths recorded in the United States demanding the treatment with novel and efficient methods. Also, a rise in the approval of new drugs by the FDA and the launch of new products in the forecast period and is anticipated to provide lucrative opportunities that fuel market growth globally. In addition, the advancements in single-use bioprocess technologies increased the affordability and sustainability of vaccine production along with a reduction in the risk of cross-contamination is expected to boost the market across the forecast period.

Key Market Trends

2D Bioprocess Containers Segment is Expected to Hold the Major Market Share in the Global Bioprocess containers Market

  • The 2D bioprocess containers segment is expected to account for the largest share in the market revenue over the forecast period. This dominance is owing to their ability to speed up the current biopharmaceutical production process and are helpful in storage, fluid management, and media preparation. The 3D bioprocess containers segment is estimated to witness the highest growth rate during the forecast period due to increased adoption of these systems with decreased labor costs and faster processing using these containers which propelling the market growth.
  • Based on the application, the upstream process segment is estimated to register for the highest revenue share during the forecast period. The lucrative revenue from these processes is due to their wide use of bioprocess containers, particularly during fermentation, mixing, and culture media processing thus contributing to the growth of the global bioprocess container market.
  • Based on end-user, the biopharmaceutical companies segment is expected to dominate the market during the forecast period which majorly employs the single-use bioprocess container systems due to their cost-effectiveness by minimizing utility requirements and reduce the cleaning validation efforts thus result in a reduction in the overall cost of production. Thus, biopharmaceutical companies contribute to the growth of the market.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall bioprocess container market throughout the forecast period. This dominance is mainly owing to the high demand for biopharmaceuticals due to the rise in geriatric population and advanced health care infrastructure in the United States. Also, due to the presence of leading players focusing on research activities and huge investments in health care by manufacturers based in the United States contributes to its outstanding market growth globally.

Next to North America, Europe holds for the second-highest market globally with a rise in the life science R&D companies and manufacturing units of biologics and biosimilars in the region. Thus, the requirement of bioprocess containers increased rapidly to minimize the process complications and contamination risks primarily contribute to the growth of the market in the region propelling the global market.

The Asia Pacific market is anticipated to witness the highest CAGR during the forecast period owing to the significant investments by key market players coupled with the increasing government support in the region. The advanced developments in countries like China, India, and Japan with a high R&D infrastructure of pharmaceutical manufacturing and comparatively cheaper labor cost fuel the market revenue. For instance, in May 2017, Merck opened its first joint bioprocess Scale-Up laboratory in Bengaluru, India with Stelis Biopharma to provide end-to-end solutions for pre-clinical, clinical and commercial supply indicating huge growth for the market in the region.

Competitive Landscape

The global bioprocess containers market is moderately competitive and consists of several major players. Some prominent players that are currently dominating the market In terms of market share are acquiring the products, entering into partnerships with the other companies to consolidate their market positions across the globe and while others are distributing products. Some of the companies which are currently dominating the market are Thermo Fisher Scientific Inc, General Electric Co, Saint-Gobain S.A, Lonza Group AG, and Avantor Inc

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.
Note: Product cover images may vary from those shown


  • Avantor Inc
  • Cole-Parmer Instrument Co
  • Danaher Life Sciences
  • General Electric Co
  • Lonza Group AG
  • Merck KGaA

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Demand for Biologics and Lower Risk of Cross-Contamination
4.2.2 Vaccine Production Using Single-Use Disposable Technologies
4.3 Market Restraints
4.3.1 High Cost of Equipments Coupled with Impurity Issues Related to Leachables and Extractables
4.3.2 Stringent Regulatory Framework for Manufacturing Facilities with Bioprocess Containers
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Type of Containers
5.1.1 2D Bioprocess Containers
5.1.2 3D Bioprocess Containers
5.1.3 Other Containers and Accessories
5.2 By Application
5.2.1 Upstream Process
5.2.2 Downstream Process
5.2.3 Process Development
5.3 By End Users
5.3.1 Biopharmaceutical Companies
5.3.2 Life Science R&D Companies
5.3.3 Others
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle East and Africa GCC South Africa Rest of Middle East and Africa
5.4.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Thermo Fisher Scientific Inc.
6.1.2 General Electric Co
6.1.3 Saint-Gobain S.A
6.1.4 Lonza Group AG
6.1.5 Avantor Inc
6.1.6 Merck KGaA
6.1.7 Sartorius AG
6.1.8 Danaher Life Sciences
6.1.9 Cole-Parmer Instrument Co
6.1.10 Biomass Sensor Singapore Pte
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Thermo Fisher Scientific Inc.
  • General Electric Co
  • Saint-Gobain S.A
  • Lonza Group AG
  • Avantor Inc
  • Merck KGaA
  • Sartorius AG
  • Danaher Life Sciences
  • Cole-Parmer Instrument Co
  • Biomass Sensor Singapore Pte
Note: Product cover images may vary from those shown